← Open Payments lookup

MARY KRETCHMAN: Open Payments

NPI 1164203006 · OAKLAND, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$877 in 40 payments from 13 companies in 2025. Trend: 2023 $54 · 2024 $833 · 2025 $877

Food & beverage: $877
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP6$303
ABBVIE INC.16$231
Astellas Pharma US Inc3$68
Bayer Healthcare Pharmaceuticals Inc.3$58
Exact Sciences Corporation2$35
Boehringer Ingelheim Pharmaceuticals, Inc.2$32
Axsome Therapeutics, Inc.2$30
Merck Sharp & Dohme LLC1$23
Alnylam Pharmaceuticals Inc.1$23
PFIZER INC.1$20

Products named: AIRSUPRA, FARXIGA, QULIPTA, VRAYLAR, Veozah, Kerendia, JARDIANCE, Auvelity.

Industry payments across MD — which companies pay providers there.